Grace Capital’s Novartis NVS Stock Holding History

Grace Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,103	Closed	-$1.39M	–	216
2018 Q4	$1.39M	Buy	+18,103	New	+$1.41M	0.65%	56
2018 Q2	–	Sell	-65,826	Closed	-$4.73M	–	227
2018 Q1	$4.73M	Sell	65,826 -18,156	-22%	-$1.38M	2.52%	15
2017 Q4	$6.32M	Buy	83,982 +24,072	+40%	+$1.82M	2.22%	17
2017 Q3	$4.61M	Buy	59,910 +8,141	+16%	+$615K	1.67%	23
2017 Q2	$3.87M	Buy	51,769 +6,138	+13%	+$435K	1.55%	26
2017 Q1	$3.04M	Buy	45,631 +340	+0.8%	+$22.7K	1.25%	35
2016 Q4	$295K	Sell	45,291 -632	-1%	-$41K	0.13%	73
2016 Q3	$3.25M	Sell	45,923 -938	-2%	-$68.4K	1.42%	35
2016 Q2	$3.46M	Sell	46,861 -192	-0.4%	-$13.3K	1.45%	32
2016 Q1	$3.05M	Sell	47,053 -4,469	-9%	-$304K	1.37%	38
2015 Q4	$3.97M	Buy	51,522 +3,584	+7%	+$285K	1.87%	11
2015 Q3	$4.43M	Hold	47,938	–	–	1.83%	14
2015 Q2	$4.43M	Sell	47,938 -45,155	-49%	-$4.14M	1.83%	14
2015 Q1	$8.23M	Sell	93,093 -14,434	-13%	-$1.28M	1.85%	11
2014 Q4	$8.93M	Buy	107,527 +14,357	+15%	+$1.19M	2.15%	3
2014 Q3	$7.86M	Buy	93,170 +3,455	+4%	+$280K	2.23%	3
2014 Q2	$7.28M	Buy	89,715 +65,364	+268%	+$5.14M	2%	5
2014 Q1	$1.85M	Buy	24,351 +1,785	+8%	+$130K	1.95%	8
2013 Q4	$1.63M	Buy	22,566 +547	+2%	+$38K	1.88%	10
2013 Q3	$1.51M	Buy	22,019 +1,161	+6%	+$76.8K	1.91%	11
2013 Q2	$1.32M	Buy	+20,858	New	+$1.36M	1.79%	13

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Grace Capital's NVS Position: Q1 2019 in Review

Grace Capital sold out of Novartis (NVS) in Q1 2019, closing a stake of 18,103 shares — an estimated $1.39M sold.

Grace Capital first reported a position in NVS in Q2 2013 and held it in 21 quarters. The position peaked at $8.93M in Q4 2014. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

Grace Capital reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
Grace Capital sold 18,103 Novartis shares in Q1 2019, an estimated $1.39M.
Grace Capital first reported a position in Novartis in Q2 2013 and held it in 21 quarters.
Grace Capital's Novartis position peaked at $8.93M in Q4 2014.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Grace Capital's 13F filing for Q1 2019, filed 15 May 2019.